28.96

0.52% -0.15

Dopo l'orario di chiusura: 28.96

Guardant Health Inc (GH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché GH Giù? Forum Previsione

Precedente Chiudi:

$29.11

Aprire:

$29.15

Volume 24 ore:

2.37M

Relative Volume:

1.15

Capitalizzazione di mercato:

$3.58B

Reddito:

$643.81M

Utile/perdita netta:

$-490.76M

Rapporto P/E:

-7.133

EPS:

-4.06

Flusso di cassa netto:

$-299.27M

1 W Prestazione:

-1.36%

1M Prestazione:

+35.45%

6M Prestazione:

+14.20%

1 anno Prestazione:

+24.40%

Intervallo 1D:

$28.69

$29.74

Intervallo di 1 settimana:

$28.69

$32.26

Portata 52W:

$15.81

$37.04

Guardant Health Inc Stock (GH) Company Profile

Nome

Guardant Health Inc

Settore

Healthcare (1196)

Industria

Diagnostics & Research (56)

Telefono

855-698-8887

Indirizzo

3100 HANOVER STREET, PALO ALTO

Dipendente

1,779

Cinguettio

@guardanthealth

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

GH's Discussions on Twitter

Confronta GH con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
GH	28.96	3.58B	643.81M	-490.76M	-299.27M	-4.06
TMO	501.29	192.46B	42.37B	6.14B	7.78B	15.26
DHR	230.06	166.23B	23.74B	3.89B	4.98B	7.93
A	126.92	36.47B	6.50B	1.41B	1.42B	3.82
IQV	191.04	34.67B	15.32B	1.41B	1.96B	5.95
IDXX	419.83	34.38B	3.84B	866.24M	792.60M	9.80

Guardant Health Inc Stock (GH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-12-14	Iniziato	Guggenheim	Neutral
2023-12-13	Iniziato	Wolfe Research	Peer Perform
2023-11-13	Aggiornamento	Raymond James	Mkt Perform → Outperform
2023-09-28	Iniziato	Bernstein	Outperform
2023-09-27	Aggiornamento	Piper Sandler	Neutral → Overweight
2023-07-05	Ripresa	JP Morgan	Overweight
2023-05-26	Aggiornamento	Citigroup	Neutral → Buy
2023-05-05	Iniziato	UBS	Buy
2023-03-09	Downgrade	Citigroup	Buy → Neutral
2023-01-05	Iniziato	Scotiabank	Sector Outperform
2022-11-01	Downgrade	Piper Sandler	Overweight → Neutral
2022-10-19	Iniziato	Craig Hallum	Buy
2022-10-06	Iniziato	Stephens	Overweight
2022-08-25	Iniziato	Credit Suisse	Outperform
2022-06-03	Iniziato	Piper Sandler	Overweight
2022-04-28	Ripresa	BTIG Research	Buy
2022-02-24	Reiterato	Canaccord Genuity	Buy
2022-02-24	Reiterato	Citigroup	Buy
2022-02-24	Reiterato	Cowen	Outperform
2022-02-24	Reiterato	Morgan Stanley	Overweight
2022-02-24	Reiterato	SVB Leerink	Outperform
2022-02-24	Reiterato	Stifel	Buy
2022-02-24	Reiterato	Wells Fargo	Overweight
2021-10-15	Ripresa	Cowen	Outperform
2021-06-15	Iniziato	Raymond James	Mkt Perform
2021-06-03	Iniziato	Goldman	Buy
2021-05-25	Iniziato	Wells Fargo	Overweight
2021-01-11	Iniziato	Stifel	Buy
2020-09-09	Iniziato	Morgan Stanley	Overweight
2020-06-12	Iniziato	BTIG Research	Buy
2020-02-21	Iniziato	Guggenheim	Buy
2020-01-07	Iniziato	Citigroup	Buy
2019-08-07	Reiterato	Canaccord Genuity	Buy
2019-04-16	Iniziato	Canaccord Genuity	Buy
2019-04-10	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-02-28	Reiterato	BofA/Merrill	Neutral
2018-10-29	Iniziato	BofA/Merrill	Neutral
2018-10-29	Iniziato	JP Morgan	Overweight
2018-10-29	Iniziato	William Blair	Outperform

Mostra tutto

Guardant Health Inc Borsa (GH) Ultime notizie

Nov 17, 2024

Sumitomo Mitsui Trust Group Inc. Boosts Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Nov 17, 2024

Nov 16, 2024

Guardant Health (FRA:5GH) Total Inventories : €65.1 Mil (As of Sep. 2024) - GuruFocus.com

Nov 16, 2024

Nov 15, 2024

Natera Exec Calls Guardant's Cancer Test Claims 'Dangerous' - Law360

Nov 15, 2024

Nov 14, 2024

Insider Selling: Director Meghan Joyce Sells Shares of Guardant Health Inc (GH) - GuruFocus.com

Nov 14, 2024

Guardant Health director Ian Clark sells shares worth $244,929 - Investing.com

Nov 14, 2024

Nov 13, 2024

CADIAN CAPITAL MANAGEMENT, LP's Strategic Acquisition in Guardan - GuruFocus.com

Nov 13, 2024

Guardant Atty Accuses Natera CEO Of Dishonesty At Trial - Law360

Nov 13, 2024

Guardant Health Awards 233K RSUs, Stock Options to New Employees in Incentive Plan | GH Stock News - StockTitan

Nov 13, 2024

Guardant Health, Inc. (NASDAQ:GH) Shares Sold by Baillie Gifford & Co. - MarketBeat

Nov 13, 2024

Multi-cancer Early Detection Market Next Big Thing| Major Giants Exact Sciences, AnchorDx, Guardant Health - openPR

Nov 09, 2024

Nov 08, 2024

Wellington Management Group LLP Bolsters Stake in Guardant Healt - GuruFocus.com

Nov 08, 2024

Guardant Health, Inc. (NASDAQ:GH) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 08, 2024

Market Participants Recognise Guardant Health, Inc.'s (NASDAQ:GH) Revenues Pushing Shares 36% Higher - Simply Wall St

Nov 08, 2024

Guardant Health, Inc. (NASDAQ:GH) Shares Bought by ARK Investment Management LLC - MarketBeat

Nov 08, 2024

Guardant Health Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 08, 2024

Why Guardant Health Stock Blasted 13% Higher on Thursday - MSN

Nov 08, 2024

Nov 07, 2024

Ex-Natera VP Defends Ad Campaign Against Rival Guardant - Law360

Nov 07, 2024

Guardant Health (GH) Stock Surges on Strong Q3 Earnings - GuruFocus.com

Nov 07, 2024

Guardant Health Pops 13% On An 'Impressive' Beat Following Exact Sciences' Flop - Yahoo! Voices

Nov 07, 2024

Leerink stays bullish on Guardant Health stock, citing robust growth prospects - Investing.com Canada

Nov 07, 2024

JPMorgan Chase & Co. Raises Guardant Health (NASDAQ:GH) Price Target to $50.00 - MarketBeat

Nov 07, 2024

Guardant Health (NASDAQ:GH) Shares Gap Up Following Analyst Upgrade - MarketBeat

Nov 07, 2024

Guardant Health (NASDAQ:GH) Price Target Raised to $36.00 at The Goldman Sachs Group - MarketBeat

Nov 07, 2024